Celsion, Focused Ultrasound support HIFU trials
Article Thumbnail ImageMay 2, 2012 -- Medical R&D firm Celsion and the Focused Ultrasound Foundation said they are supporting preclinical research designed to explore the use of Celsion's ThermoDox drug candidate in combination with MR-guided, high-intensity focused ultrasound (HIFU) for treating pancreatic cancer.

To view the remainder of this article, and other exclusive content, you must first sign-in or register using the options below.
(Helptag:PaywallArticleLoginMessage)
Member Sign In:
  MemberID or E-mail Address:
  Password:
(?)

New AuntMinnie.com Members

Becoming a Member is FREE!

  • Real-time radiology-specific news
  • Case of the Day and Teaching Files
  • Focused topics digital communities
  • Lively, discussion groups
  • Medical imaging bookstore
  • SalaryScan
  • Job Boards
  • OnLine CMe/CE
  • Bookstore, market reports, more …
  • Conference Calendar
  • User-controlled eNewsletters
  • … registration is FREE and easy!
  • The studies involving ThermoDox, Celsion's phase III heat-activated liposomal encapsulation of doxorubicin, are being conducted at the University of Washington School of Medicine by director of endoscopic research Dr. Joo Ha Hwang, PhD. Celsion is supporting the research by contributing ThermoDox supplies, while the Focused Ultrasound Foundation is funding a preclinical study.


    || About || Advertising || Bookstore || Breast MRI || Career Center || Case of the Day || Communities || Conferences || Contact Us || ECR News 2013 || Education || Equipment Classifieds || Facebook || Forums || Home || Links || Marketplace || Mobile || Molecular Breast Imaging || New Installations || News in Brief || People in the News || Privacy Policy || RSNA News 2012 || Reference || Salary Survey Results || Trends in Radiology || Twitter || Vendor Connect || Webinars || XML/RSS ||

    Copyright © 2013 AuntMinnie.com. All Rights Reserved.